Grace Therapeutics, Inc. (GRCE) insider trading

{
  "status": "OK",
  "results": [
    {
      "tickers": [
        "ACST",
        "GRCE"
      ],
      "issuer_cik": "0001444192",
      "owner_cik": "0001595855",
      "accession_number": "0001493152-26-047949",
      "form_type": "4",
      "filing_date": "2026-10-21",
      "period_of_report": "2026-10-19",
      "issuer_name": "Grace Therapeutics, Inc.",
      "issuer_trading_symbol": "GRCE",
      "owner_name": "Opaleye Management Inc.",
      "is_director": false,
      "is_officer": false,
      "is_ten_percent_owner": true,
      "is_other": false,
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock, par value $0.0001 per share",
      "transaction_timeliness": "O",
      "aff_10b5_one": false,
      "transaction_date": "2026-10-19",
      "transaction_code": "P",
      "equity_swap_involved": false,
      "transaction_shares": 4256,
      "transaction_price_per_share": 1.88,
      "transaction_acquired_disposed": "A",
      "shares_owned_following_transaction": 2948610,
      "transaction_value": 8001.28,
      "not_subject_to_section_16": false,
      "direct_or_indirect": "I",
      "nature_of_ownership": "By Opaleye, L.P.",
      "footnotes": [
        {
          "id": "F1",
          "description": "Represents securities owned directly by Opaleye, L.P. (the \"Fund\"). As the investment manager of the Fund, Opaleye Management, Inc. may be deemed to beneficially own the securities owned directly by the Fund."
        },
        {
          "id": "F2",
          "description": "Opaleye Management, Inc. disclaims beneficial ownership of the shares reported herein except to the extent of its pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that Opaleye Management, Inc. is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or for any other purpose."
        }
      ]
    },
    {
      "tickers": [
        "ACST",
        "GRCE"
      ],
      "issuer_cik": "0001444192",
      "owner_cik": "0001595855",
      "accession_number": "0001493152-26-047473",
      "form_type": "4",
      "filing_date": "2026-10-16",
      "period_of_report": "2026-10-14",
      "issuer_name": "Grace Therapeutics, Inc.",
      "issuer_trading_symbol": "GRCE",
      "owner_name": "Opaleye Management Inc.",
      "is_director": false,
      "is_officer": false,
      "is_ten_percent_owner": true,
      "is_other": false,
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock, par value $0.0001 per share",
      "transaction_timeliness": "O",
      "aff_10b5_one": false,
      "transaction_date": "2026-10-15",
      "transaction_code": "P",
      "equity_swap_involved": false,
      "transaction_shares": 23485,
      "transaction_price_per_share": 1.9453,
      "transaction_acquired_disposed": "A",
      "shares_owned_following_transaction": 2908007,
      "transaction_value": 45685.3705,
      "not_subject_to_section_16": false,
      "direct_or_indirect": "I",
      "nature_of_ownership": "By Opaleye, L.P.",
      "footnotes": [
        {
          "id": "F3",
          "description": "The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.90 to $1.95. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range."
        },
        {
          "id": "F1",
          "description": "Represents securities owned directly by Opaleye, L.P. (the \"Fund\"). As the investment manager of the Fund, Opaleye Management, Inc. may be deemed to beneficially own the securities owned directly by the Fund."
        },
        {
          "id": "F5",
          "description": "Opaleye Management, Inc. disclaims beneficial ownership of the shares reported herein except to the extent of its pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that Opaleye Management, Inc. is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or for any other purpose."
        }
      ]
    }
  ]
}

// trimmed to 2 results

The response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.